Hydrogen peroxide contributes to motor dysfunction in ulcerative colitis

American Journal of Physiology - Gastrointestinal and Liver Physiology

Volumn 286, Issue 5 49-5, 2004, Pages

  Cao, Weibiao ^a   Vrees, Matthew D ^a   Kirber, Michael T ^b   Fiocchi, Claudio ^c   Pricolo, Victor E ^a  

^a RHODE ISLAND HOSPITAL   (United States)

^b BOSTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c CASE WESTERN RESERVE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Calcium; Colon; Human; Neurokinin A; Smooth muscle

Indexed keywords

CALCIUM; CATALASE; ETHYLENE GLYCOL 1,2 BIS(2 AMINOPHENYL) ETHER N,N,N',N' TETRAACETIC ACID; HYDROGEN PEROXIDE; NEUROKININ A; NEUROTRANSMITTER; POTASSIUM CHLORIDE; SCAVENGER; THAPSIGARGIN;

ARTICLE; CALCIUM CELL LEVEL; CALCIUM TRANSPORT; CELL ISOLATION; CELL LEVEL; CELL SIZE; COLON MOTILITY; CONTROLLED STUDY; CULTURE MEDIUM; HUMAN; HUMAN CELL; HUMAN TISSUE; INTESTINE CONTRACTION; MOTOR DYSFUNCTION; MUSCLE FIBER CONTRACTION; NORMAL HUMAN; PRIORITY JOURNAL; SIGMOID; SIGNAL TRANSDUCTION; SMOOTH MUSCLE FIBER; ULCERATIVE COLITIS;

CALCIUM; CALCIUM SIGNALING; CATALASE; COLITIS, ULCERATIVE; COLON, SIGMOID; GASTROINTESTINAL MOTILITY; HUMANS; HYDROGEN PEROXIDE; NEUROKININ A; POTASSIUM CHLORIDE;

EID: 1942519785     PISSN: 01931857     EISSN: None     Source Type: Journal    
DOI: 10.1152/ajpgi.00414.2003     Document Type: Article

References (51)

1. Bae YS, Kang SW, Seo MS, Baines IC, Tekle E, Chock PB, and Rhee SG. Epidermal growth factor (EGF)-induced generation of hydrogen peroxide. Role in EGF receptor-mediated tyrosine phosphorylation. J Biol Chem 272: 217-221, 1997.
2. Biancani P, Zabinski M, Kerstein M, and Behar J. Lower esophageal sphincter mechanics: anatomic and physiologic relationships of the esophagogastric junction of the cat. Gastroenterology 82: 468-475, 1982.
3. Blau S, Kohen R, Bass P, and Rubinstein A. The effect of local attachment of cationized antioxidant enzymes on experimental colitis in the rat. Pharm Res 17: 1077-1084, 2000.
4. 2+ stores in acute experimental esophagitis (AE) in the cat (Abstract). Gastroenterology 120: A58, 2001.
5. 2 receptors mediate neurally induced contraction of human sigmoid circular smooth muscle. Gastroenterology 119: 51-61, 2000.
6. Cappello M, Keshav S, Prince C, Jewell DP, and Gordon S. Detection of mRNAs for macrophage products in inflammatory bowel disease by in situ hybridisation. Gut 33: 1214-1219, 1992.
7. Cohen JD, Kao HW, Tan ST, and Snape WJJ. Effect of acute experimental colitis on rabbit colonic smooth muscle. Am J Physiol Gastrointest Liver Physiol 251: G538-G545, 1986.
8. 2+-ATPase (sarcoplasmic reticulum) interaction reveals a two-step binding mechanism and picomolar inhibition. J Biol Chem 270: 11731-11734, 1995.
9. Dijkstra G, Moshage H, van Dullemen HM, de Jager-Krikken A, Tiebosch AT, Kleibeuker JH, Jansen PL, and van Goor H. Expression of nitric oxide synthases and formation of nitrotyrosine and reactive oxygen species in inflammatory bowel disease. J Pathol 186: 416-421, 1998.
10. Fiocchi C. Inflammatory bowel disease: etiology and pathogenesis. Gastroenterology 115: 182-205, 1998.
11. Gonzalez A and Sarna SK. Different types of contractions in rat colon and their modulation by oxidative stress. Am J Physiol Gastrointest Liver Physiol 280: G546-G554, 2001.
12. 2+ pumps of coronary artery. Am J Physiol Cell Physiol 255: C297-C303, 1988.
13. Grover AK, Samson SE, and Fomin VP. Peroxide inactivates calcium pumps in pig coronary artery. Am J Physiol Heart Circ Physiol 263: H537-H543, 1992.
14. 2+ pump. Am J Physiol Cell Physiol 269: C546-C553, 1995.
15. 2+ indicators with greatly improved fluorescence properties. J Biol Chem 260: 3440-3450, 1985.
16. Guerini D, Garcia-Martin E, Zecca A, Guidi F, and Carafoli E. The calcium pump of the plasma membrane: membrane targeting, calcium binding sites, tissue-specific isoform expression. Acta Physiol Scand Suppl 643: 265-273, 1998.
17. 2+ signaling pathways in intestinal muscle cells. J Pharmacol Exp Ther 270: 236-243, 1994.
18. Ishiguro Y. Mucosal proinflammatory cytokine production correlates with endoscopic activity of ulcerative colitis. J Gastroenterol 34: 66-74, 1999.
19. Izzo RS, Witkon K, Chen AI, Hadjiyane C, Weinstein MI, and Pellecchia C. Neutrophil-activating peptide (interleukin-8) in colonic mucosa from patients with Crohn's disease. Scand J Gastroenterol 28: 296-300, 1993.
20. Jewell D. Ulcerative colitis. In: Sleisenger and Fordtran's Gastrointestinal and Liver Disease (6th ed.), edited by Feldman M, Scharschmidt BF, and Sleisenger MH. Philadelphia: Saunders, 1998, p. 1734-1758.
21. Jones JJ, Dietz NJ, Heaps CL, Parker JL, and Sturek M. Calcium buffering in coronary smooth muscle after chronic occlusion and exercise training. Cardiovasc Res 51: 359-367, 2001.
22. Koch TR, Carney JA, Go VL, and Szurszewski JH. Spontaneous contractions and some electrophysiologic properties of circular muscle from normal sigmoid colon and ulcerative colitis. Gastroenterology 95: 77-84, 1988.
23. 2-terminal kinase in rat aortic smooth muscle cells. FASEB J 15: 1472-1474, 2001.
24. Kourie JI. Interaction of reactive oxygen species with ion transport mechanisms. Am J Physiol Cell Physiol 275: C1-C24, 1998.
25. Kusugami K, Fukatsu A, Tanimoto M, Shinoda M, Haruta J, Kuroiwa A, Ina K, Kanayama K, Ando T, Matsuura T, Yamaguchi T, Morise K, Ieda M, Iokawa H, Ishihara A, and Sarai S. Elevation of interleukin-6 in inflammatory bowel disease is macrophage- and epithelial cell-dependent. Dig Dis Sci 40: 949-959, 1995.
26. 2+-ATPase activity of masseter muscle sarcoplasmic reticulum. Jpn J Pharmacol 67: 729-734, 1995.
27. Lu G, Qian X, Berezin I, Teleford GL, Huizinga JD, and Sarna SK. Inflammation modulates in vitro colonic myoelectric and contractile activity and interstitial cells of Cajal. Am J Physiol Gastrointest Liver Physiol 273: G1233-G1245, 1997.
28. Mahadev K, Zilbering A, Zhu L, and Goldstein BJ. Insulin-stimulated hydrogen peroxide reversibly inhibits protein-tyrosine phosphatase lb in vivo and enhances the early insulin action cascade. J Biol Chem 276: 21938-21942, 2001.
29. Murch SH, Lamkin VA, Savage MO, Walker-Smith JA, and MacDonald TT. Serum concentrations of tumour necrosis factor alpha in childhood chronic inflammatory bowel disease. Gut 32: 913-917, 1991.
30. Okatani Y, Wakatsuki A, and Reiter RJ. Melatonin counteracts potentiation by homocysteine of KCl-induced vasoconstriction in human umbilical artery: relation to calcium influx. Biochem Biophys Res Commun 280: 940-944, 2001.
31. Papadakis KA and Targan SR. Current theories on the causes of inflammatory bowel disease. Gastroenterol Clin North Am 28: 283-296, 1999.
32. Perkins WJ, Lorenz RR, Bogoger M, Warner DO, Cremo CR, and Jones KA. A novel mechanism by which hydrogen peroxide decreases calcium sensitivity in airway smooth muscle. Am J Physiol Lung Cell Mol Physiol 284: L324-L332, 2003.
33. Podolsky DK. The current future understanding of inflammatory bowel disease. Best Pract Res Clin Gastroenterol 16: 933-943, 2002.
34. Podolsky DK. Inflammatory bowel disease. N Engl J Med 347: 417-429, 2002.
35. Rowe GT, Manson NH, Caplan M, and Hess ML. Hydrogen peroxide and hydroxyl radical mediation of activated leukocyte depression of cardiac sarcoplasmic reticulum. Circ Res 53: 584-591, 1983.
36. 2 in cultured endothelial cells. Arch Biochem Biophys 302: 348-355, 1993.
37. Sands BE. Novel therapies for inflammatory bowel disease. Gastroenterol Clin North Am 28: 323-351, 1999.
38. Shanahan F and Targan S. Medical treatment of inflammatory bowel disease. Annu Rev Med 43: 125-133, 1992.
39. 2+ influx through L-type voltage-dependent calcium channels by hydroxyl radical in mouse cerebral cortical neurons. Brain Res Mol Brain Res 92: 12-18, 2001.
40. Simmonds NJ, Allen RE, Stevens TRJ, Van Someren RNM, Blake DR, and Rampton DS. Chemiluminescence assay of mucosal reactive oxygen metabolites in inflammatory bowel disease. Gastroenterology 103: 186-196, 1992.
41. Sims SM. Cholinergic activation of a non-selective cation current in canine gastric smooth muscle is associated with contraction. J Physiol 449: 377-398, 1992.
42. Snape WJ, Williams R, and Hyman PE. Defect in colonic smooth muscle contraction in patients with ulcerative colitis. Am J Physiol Gastrointest Liver Physiol 261: G987-G991, 1991.
43. Sundaresan M, Yu ZX, Ferrans VJ, Irani K, and Finkel T. Requirement for generation of H202 for platelet-derived growth factor signal transduction. Science 270: 296-299, 1995.
44. Thannickal VJ and Fanburg BL. Reactive oxygen species in cell signaling. Am J Physiol Lung Cell Mol Physiol 279: L1005-L1028, 2000.
45. Tomita R, Munakata K, and Tanjoh K. Role of non-adrenergic noncholinergic inhibitory nerves in the colon of patients with ulcerative colitis. J Gastroenterol 33: 48-52, 1998.
46. Tsukamoto M, Sarna S, and Condon RE. A novel motility effect of tachykinins in normal and inflamed colon. Am J Physiol Gastrointest Liver Physiol 272: G1607-G1614, 1997.
47. Vanden Hoek TL, Li C, Shao Z, Schumacker PT, and Becker LB. Significant levels of oxidants are generated by isolated cardiomyocytes during ischemia prior to reperfusion. J Mol Cell Cardiol 29: 2571-2583, 1997.
48. Vrees MD, Pricolo VE, Potenti FM, and Cao W. Abnormal motility in patients with ulcerative colitis: the role of inflammatory cytokines. Arch Surg 137: 439-445: discussion 445-436, 2002.
49. +-ATPase to hypertrophy and its marker genes in cardiac myocytes. J Biol Chem 274: 19323-19328, 1999.
50. Yavuz Y, Yuksel M, Yegen BC, and Alican I. The effect of antioxidant therapy on colonic inflammation in the rat. Res Exp Med (Berl) 199: 101-110, 1999.
51. Youngman KR, Simon PL, West GA, Cominelli F, Rachmilewitz D, Klein JS, and Fiocchi C. Localization of intestinal interleukin I activity and protein and gene expression to lamina propria cells. Gastroenterology 104: 749-758, 1993.